Dublin, Feb. 12, 2021 (GLOBE NEWSWIRE) -- The "North America Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
North America virus filtration market is expected to grow by 11.86% annually in the forecast period and reach $2,554.1 million by 2026 owing to rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D, surging need for virus removal and clearance amid COVID-19 pandemic.
Highlighted with 25 tables and 42 figures, this report is based on a holistic research of the entire North America virus filtration market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America virus filtration market in every aspect of the classification from perspectives of Product, Application, End User, and Country.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America virus filtration market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players
- Asahi Kasei Medical Co., Ltd.
- Charles River Laboratories International, Inc.
- Clean Cells
- General Electric Company
- Lonza Group AG
- Merck KGaA
- MilliporeSigma
- Pall Corporation
- Sartorius AG
- Thermo Fisher Scientific, Inc.
- Wuxi Apptec
Key Topics Covered:
1 Introduction
1.1 Industry Definition and Research Scope
1.2 Research Methodology
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Five Forces Analysis
3 Segmentation of North America Market by Product
3.1 Market Overview by Product
3.2 Consumables
3.3 Instruments
3.3.1 Filtration Systems
3.3.2 Chromatography systems
3.4 Services
4 Segmentation of North America Market by Application
4.1 Market Overview by Application
4.2 Biological Applications
4.2.1 Vaccines and Therapeutics
4.2.2 Blood and Blood Products
4.2.3 Cellular and Gene Therapy Products
4.2.4 Tissue and Tissue Products
4.2.5 Stem Cell Products
4.3 Medical Devices
4.4 Water Purification
4.5 Air Purification
4.6 Other Applications
5 Segmentation of North America Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical and Biotechnology Companies
5.3 Contract Research Organisations (CROs)
5.4 Academic & Research Institutes
5.5 Medical Device Companies
5.6 Other End Users
6 North America Market 2019-2026 by Country
6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico
7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
8 Investing in North America Market: Risk Assessment and Management
8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)
For more information about this report visit https://www.researchandmarkets.com/r/52tdos